Metastatic tumors involving the brain are an important complication in the overall management of non-small cell lung cancers. Surgery and radiation remain the cornerstones of the therapy, however, the burgeoning knowledge of tumor biology has facilitated the entry of systemically administered therapies into the clinic. This review mainly summarizes the current applications of these data to surgery, radiation therapy, chemotherapy and targeted therapy
Brain metastases risk at the time of diagnosis or during the course of disease is high in non-small ...
Non-small cell lung cancer (NSCLC) is one of the most common malignant tumors and has high morbidity...
Brain tumors include primary tumors of various intracranial tissue and secondary intracranial tumors...
Lung cancer is characterized by the highest incidence of solid tumor-related brain metastases, which...
With the improvements in systemic treatment for lung cancer, distant metastasis to sanctuary sites s...
Lung cancer is characterized by the highest incidence of solid tumor-related brain metastases, which...
Lung cancer is characterized by the highest incidence of solid tumor-related brain metastases, which...
Lung cancer is characterized by the highest incidence of solid tumor-related brain metastases, which...
Lung cancer is characterized by the highest incidence of solid tumor-related brain metastases, which...
Lung cancer is the most common primary malignancy that tends to metastasize to the brain. Owing to i...
Metastases from cells outside of the central nervous system are the most common cancer found in the ...
International audienceThe management of Non Small Cell Lung Cancer (NSCLC) brain metastases is chall...
International audienceThe management of Non Small Cell Lung Cancer (NSCLC) brain metastases is chall...
In lung cancer patients brain metastases develop with a high frequency. For years radiotherapy has b...
Brain metastases risk at the time of diagnosis or during the course of disease is high in non-small ...
Brain metastases risk at the time of diagnosis or during the course of disease is high in non-small ...
Non-small cell lung cancer (NSCLC) is one of the most common malignant tumors and has high morbidity...
Brain tumors include primary tumors of various intracranial tissue and secondary intracranial tumors...
Lung cancer is characterized by the highest incidence of solid tumor-related brain metastases, which...
With the improvements in systemic treatment for lung cancer, distant metastasis to sanctuary sites s...
Lung cancer is characterized by the highest incidence of solid tumor-related brain metastases, which...
Lung cancer is characterized by the highest incidence of solid tumor-related brain metastases, which...
Lung cancer is characterized by the highest incidence of solid tumor-related brain metastases, which...
Lung cancer is characterized by the highest incidence of solid tumor-related brain metastases, which...
Lung cancer is the most common primary malignancy that tends to metastasize to the brain. Owing to i...
Metastases from cells outside of the central nervous system are the most common cancer found in the ...
International audienceThe management of Non Small Cell Lung Cancer (NSCLC) brain metastases is chall...
International audienceThe management of Non Small Cell Lung Cancer (NSCLC) brain metastases is chall...
In lung cancer patients brain metastases develop with a high frequency. For years radiotherapy has b...
Brain metastases risk at the time of diagnosis or during the course of disease is high in non-small ...
Brain metastases risk at the time of diagnosis or during the course of disease is high in non-small ...
Non-small cell lung cancer (NSCLC) is one of the most common malignant tumors and has high morbidity...
Brain tumors include primary tumors of various intracranial tissue and secondary intracranial tumors...